News

Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief

Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

RECOVER-TLC workshop on new Long Covid clinical trials

The Sick Times

Long Covid patients can sign up for remote clinical trial notification

Clinical trial underway for potential Long Covid treatment

Nova Southeastern University and the Schmidt Initiative for Long Covid will study the efficacy of a long-acting antibody for treating Long Covid

Scientists testing if existing drugs can treat Long Covid

NewsToday.ca

Global clinical trial to test existing drugs as Long Covid treatments

Western University and Schmidt Initiative for Long Covid will enroll more than 300 patients across four continents